SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001490978-24-000057
Filing Date
2024-06-20
Accepted
2024-06-20 16:19:13
Documents
1
Period of Report
2024-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1718914747.html 4  
1 FORM 4 wk-form4_1718914747.xml 4 5965
  Complete submission text file 0001490978-24-000057.txt   7422
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Issuer) CIK: 0001490978 (see all company filings)

IRS No.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SYNERGY PHARMACEUTICALS INC. 420 LEXINGTON AVE NEW YORK NY 10020
Business Address
Sender Gary (Reporting) CIK: 0001659085 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39206 | Film No.: 241056500